ADAM9 overexpression
|
Triple Negative Breast Cancer
|
ADAM9 overexpression
|
Triple Negative Breast Cancer
|
IMGC936 Sensitive: D – Preclinical
|
IMGC936 Sensitive: D – Preclinical
|
ADAM9 overexpression
|
NSCLC
|
ADAM9 overexpression
|
NSCLC
|
IMGC936 Sensitive: D – Preclinical
|
IMGC936 Sensitive: D – Preclinical
|